TCG Crossover Management’s Adverum Biotechnologies ADVM Stock Holding History

TCG Crossover Management’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,668,174	Closed	-$7.56M	–	44
2025 Q3	$7.56M	Sell	1,668,174 -128,308	-7%	-$378K	0.37%	35
2025 Q2	$3.86M	Hold	1,796,482	–	–	0.44%	33
2025 Q1	$7.85M	Hold	1,796,482	–	–	1.07%	28
2024 Q4	$8.39M	Sell	1,796,482 -211,857	-11%	-$1.43M	0.82%	32
2024 Q3	$14.1M	Sell	2,008,339 -1	-0%	-$7	1.19%	25
2024 Q2	$13.8M	Hold	2,008,340	–	–	1.44%	22
2024 Q1	$28.4M	Buy	+2,008,340	New	+$30.5M	2.25%	21

TCG Crossover Management's ADVM Position: Q4 2025 in Review

TCG Crossover Management sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 1,668,174 shares — an estimated $7.56M sold.

TCG Crossover Management first reported a position in ADVM in Q1 2024 and held it in 7 quarters. The position peaked at $28.4M in Q1 2024. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.

TCG Crossover Management reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
TCG Crossover Management sold 1,668,174 Adverum Biotechnologies shares in Q4 2025, an estimated $7.56M.
TCG Crossover Management first reported a position in Adverum Biotechnologies in Q1 2024 and held it in 7 quarters.
TCG Crossover Management's Adverum Biotechnologies position peaked at $28.4M in Q1 2024.
0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.

Based on TCG Crossover Management's 13F filing for Q4 2025, filed 17 Feb 2026.